Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 100873

In scope icon M 1 C
QID 100873 (Type "100873" in App Search)
A 1-year-old Caucasian male is on pancreatic enzyme replacement therapy (PERT) to maintain a healthy body mass index. Sweat chloride test is 68 mmol/L (< 29 mmol/L = normal). The patient has a relative who was also on PERT but passed away in his mid-20s due to respiratory failure, and was unable to have children. Which of the following would be most improved by PERT?

Bone mineral density

59%

10/17

Expression of the autosomal dominant deletion of CFTR gene

12%

2/17

Nasal polyps

6%

1/17

Hypoglycemia

18%

3/17

A lack of respiratory infections

0%

0/17

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient’s elevated sweat chloride test and significant family history suggests cystic fibrosis (CF). Malabsorption is very common in CF patients due to pancreatic gland atrophy secondary to viscous secretions impairing pancreatic exocrine release. Impaired fat-soluble vitamin absorption, such as vitamin D, would decrease bone mineral density. Thus, PERT would improve vitamin D absorption and bone mineral density.

CF is an autosomal recessive defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene on chromosome 7. This is commonly due to a deletion of phenylalanine-508. In secretions other than the sweat gland, defects in this transporter protein dehydrates secretions, making them viscous/thickened in areas such as the pancreatic ducts. This progresses to pancreatic tissue destruction via exocrine gland atrophy and fibrosis, leading to malabsorption of nutrients, such as fat, therefore fat soluble vitamins like A, D, E, K, and CF-related diabetes. PERT is used to replace the enzymes lost in patients with pancreatic insufficiency, an important contributor to malnutrition in CF patients.

Incorrect Answers:
Answer 2: CF is an autosomal recessive disease.
Answer 3: Nasal polyps are seen in 10 – 32% of CF patients. This is not the reason why this patient is on PERT.
Answer 4: Pancreatic insufficiency in CF leads to CF-related diabetes; therefore, hypoglycemia is not expected.
Answer 5: CF patients have recurrent sinopulmonary infections. Pseudomonas aeruginosa is the most common pathogen.

Authors
Rating
Please Rate Question Quality

4.1

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(9)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options